COMMUNIQUÉS West-GlobeNewswire

Announcement About Convening of the Annual General Meeting of Olainfarm

17/05/2019 - 16:25

Announcement About Convening of the Annual General Meeting of Olainfarm Management Board of the Joint Stock company “Olainfarm” (registration number. 40003007246, registered address: Rupnicu iela 5, Olaine, LV-2114) [...]

Proposal of the Management Board of JSC “Olainfarm” regarding distribution of profit of 2018

17/05/2019 - 17:05

Proposal of the Management Board of JSC “Olainfarm” regarding distribution of profit of 2018 Olaine May 17th, 2019 The amount of net profit of JSC “Olainfarm” in 2018 is EUR 8 886 000,00 (eight million eight hundred and [...]

Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug

17/05/2019 - 17:19

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, May 17, 2019 (GLOBE [...]

Arch Biopartners Arranges Convertible Note Financing

17/05/2019 - 13:00

TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing [...]

Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit

17/05/2019 - 13:00

Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit London, UK; 17 May 2019 – Pulmocide Ltd, which is developing first-in-class inhaled anti-infectives for targeted [...]

Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting

17/05/2019 - 13:00

- ACH-4471 increased hemoglobin and nearly eliminated the need for transfusions in patients with PNH being treated with C5 inhibitor, eculizumab - BLUE BELL, Pa., May 17, 2019 (GLOBE NEWSWIRE) -- Achillion [...]

Natus to Present at William Blair 39th Annual Growth Stock Conference

17/05/2019 - 13:00

PLEASANTON, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present at the William Blair 39 [...]

ADMA Biologics Announces Pricing of Public Offering of Common Stock

17/05/2019 - 13:11

RAMSEY, N.J. and BOCA RATON, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company [...]

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®

17/05/2019 - 13:30

PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its [...]

Emerald Health Therapeutics Introduces Unique Premium CBD Oil SYNC 25 to British Columbia Recreational Marketplace

17/05/2019 - 13:58

Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]

Emerald Health Therapeutics lance l'huile de CBD de première qualité SYNC 25 sur le marché récréatif de la Colombie-Britannique

17/05/2019 - 13:58

La SYNC 25 CBD d'Emerald est une huile ultra-pure, donc sans THC et sans fumée, conçue pour répondre à un important besoin sur le marché récréatif de la C.-B. VANCOUVER, Colombie-Britannique, 17 mai 2019 (GLOBE NEWSWIRE [...]

AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York

17/05/2019 - 14:00

WALTHAM, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019 from 8:30 a.m. to 12:00 [...]

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

17/05/2019 - 14:00

WALTHAM Mass. and CRESTWOOD, Ky., May 17, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma

17/05/2019 - 14:00

Presented at the World Advanced Therapies & Regenerative Medicine Congress & Expo 2019 SYDNEY, Australia, May 17, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a [...]

CB2 Insights Announces Ticker Symbol Change on OTCQB

17/05/2019 - 14:00

TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII) (OTCQB:CBIIF) a leading technology company focused on mainstreaming medical cannabis to the healthcare industry through Real- [...]

Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results

17/05/2019 - 14:05

SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's preliminary [...]

International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019

17/05/2019 - 14:30

CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

Orion Corporation: Managers' transactions - Riikka Westerlund

17/05/2019 - 14:59

ORION CORPORATION MANAGERS' TRANSACTIONS 17 May 2019 at 16.00 EEST Orion Corporation: Managers' transactions - Riikka Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]

Precision Therapeutics Gains Extension for Nasdaq Compliance

17/05/2019 - 15:00

MINNEAPOLIS, May 17, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

COMMUNIQUÉS West-GlobeNewswire

Pages